Walls close in on VistaGen's PALISADE anxiety trial program in wake of phase 3 failure

After announcing last month that a late-stage trial for a social anxiety nose spray was unsuccessful, VistaGen is pausing another phase 3 trial to see whether it’s worth continuing.